Global Plasma-derived Therapies Market Growth (Status and Outlook) 2023-2029

March 2023 | 84 pages | ID: G7D074D8CC58EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.

According to this study, the global Plasma-derived Therapies market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Therapies market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Albumin
• Immunoglobulin
• Factor VIII
• Others

Segmentation by Application:

• Hemophilia
• Primary Immunodeficiencies (PIDs)
• Idiopathic Thrombocytopenic Purpura (ITP)
• COVID-19
• Others

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• CSL Behring LLC
• Shire
• Bayer
• Kedrion
• Takeda
• Biotest
• Octaparma
• Bio Products Laboratory (BPL)
• LFB
• Grifols

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Plasma-derived Therapies Market Size 2024-2029
  2.1.2 Plasma-derived Therapies Market Size CAGR by Region
2.2 Plasma-derived Therapies Segment by Type
  2.2.1 Albumin
  2.2.2 Immunoglobulin
  2.2.3 Factor VIII
  2.2.4 Others
2.3 Plasma-derived Therapies Market Size by Type
  2.3.1 Global Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
  2.3.2 Global Plasma-derived Therapies Market Size Growth Rate by Type (2024-2029)
2.4 Plasma-derived Therapies Segment by Application
  2.4.1 Hemophilia
  2.4.2 Primary Immunodeficiencies (PIDs)
  2.4.3 Idiopathic Thrombocytopenic Purpura (ITP)
  2.4.4 COVID-19
  2.4.5 Others
2.5 Plasma-derived Therapies Market Size by Application
  2.5.1 Global Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
  2.5.2 Global Plasma-derived Therapies Market Size Growth Rate by Application (2024-2029)

3 PLASMA-DERIVED THERAPIES KEY PLAYERS

3.1 Date of Key Players Enter into Plasma-derived Therapies
3.2 Key Players Plasma-derived Therapies Product Offered
3.3 Key Players Plasma-derived Therapies Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Plasma-derived Therapies Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 PLASMA-DERIVED THERAPIES BY REGIONS

4.1 Plasma-derived Therapies Market Size by Regions (2024-2029)
4.2 United States Plasma-derived Therapies Market Size Growth (2024-2029)
4.3 China Plasma-derived Therapies Market Size Growth (2024-2029)
4.4 Europe Plasma-derived Therapies Market Size Growth (2024-2029)
4.5 Rest of World Plasma-derived Therapies Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States Plasma-derived Therapies Market Size by Type (2024-2029)
5.2 United States Plasma-derived Therapies Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe Plasma-derived Therapies Market Size by Type (2024-2029)
6.2 Europe Plasma-derived Therapies Market Size by Application (2024-2029)

7 CHINA

7.1 China Plasma-derived Therapies Market Size by Type (2024-2029)
7.2 China Plasma-derived Therapies Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World Plasma-derived Therapies Market Size by Type (2024-2029)
8.2 Rest of World Plasma-derived Therapies Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN PLASMA-DERIVED THERAPIES

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 CSL Behring LLC
  11.1.1 CSL Behring LLC Company Details
  11.1.2 CSL Behring LLC Plasma-derived Therapies Product Offered
  11.1.3 CSL Behring LLC Plasma-derived Therapies Market Size (2023 VS 2029)
  11.1.4 CSL Behring LLC Main Business Overview
  11.1.5 CSL Behring LLC News
11.2 Shire
  11.2.1 Shire Company Details
  11.2.2 Shire Plasma-derived Therapies Product Offered
  11.2.3 Shire Plasma-derived Therapies Market Size (2023 VS 2029)
  11.2.4 Shire Main Business Overview
  11.2.5 Shire News
11.3 Bayer
  11.3.1 Bayer Company Details
  11.3.2 Bayer Plasma-derived Therapies Product Offered
  11.3.3 Bayer Plasma-derived Therapies Market Size (2023 VS 2029)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer News
11.4 Kedrion
  11.4.1 Kedrion Company Details
  11.4.2 Kedrion Plasma-derived Therapies Product Offered
  11.4.3 Kedrion Plasma-derived Therapies Market Size (2023 VS 2029)
  11.4.4 Kedrion Main Business Overview
  11.4.5 Kedrion News
11.5 Takeda
  11.5.1 Takeda Company Details
  11.5.2 Takeda Plasma-derived Therapies Product Offered
  11.5.3 Takeda Plasma-derived Therapies Market Size (2023 VS 2029)
  11.5.4 Takeda Main Business Overview
  11.5.5 Takeda News
11.6 Biotest
  11.6.1 Biotest Company Details
  11.6.2 Biotest Plasma-derived Therapies Product Offered
  11.6.3 Biotest Plasma-derived Therapies Market Size (2023 VS 2029)
  11.6.4 Biotest Main Business Overview
  11.6.5 Biotest News
11.7 Octaparma
  11.7.1 Octaparma Company Details
  11.7.2 Octaparma Plasma-derived Therapies Product Offered
  11.7.3 Octaparma Plasma-derived Therapies Market Size (2023 VS 2029)
  11.7.4 Octaparma Main Business Overview
  11.7.5 Octaparma News
11.8 Bio Products Laboratory (BPL)
  11.8.1 Bio Products Laboratory (BPL) Company Details
  11.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offered
  11.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2023 VS 2029)
  11.8.4 Bio Products Laboratory (BPL) Main Business Overview
  11.8.5 Bio Products Laboratory (BPL) News
11.9 LFB
  11.9.1 LFB Company Details
  11.9.2 LFB Plasma-derived Therapies Product Offered
  11.9.3 LFB Plasma-derived Therapies Market Size (2023 VS 2029)
  11.9.4 LFB Main Business Overview
  11.9.5 LFB News
11.10 Grifols
  11.10.1 Grifols Company Details
  11.10.2 Grifols Plasma-derived Therapies Product Offered
  11.10.3 Grifols Plasma-derived Therapies Market Size (2023 VS 2029)
  11.10.4 Grifols Main Business Overview
  11.10.5 Grifols News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Plasma-derived Therapies Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Factor VIII
Table 5. Major Players of Others
Table 6. Global Plasma-derived Therapies Market Size by Type (2024-2029) ($ Millions)
Table 7. Global Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Table 8. Global Plasma-derived Therapies Market Size by Application (2024-2029) ($ Millions)
Table 9. Global Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Table 10. Date of Global Key Players Enter into Plasma-derived Therapies Market
Table 11. Global Key Players Plasma-derived Therapies Product Offered
Table 12. Key Players Plasma-derived Therapies Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players Plasma-derived Therapies Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. Plasma-derived Therapies New Product/Technology Launches
Table 18. Plasma-derived Therapies Industry Partnerships, Agreements, and Collaborations
Table 19. Plasma-derived Therapies Industry Mergers and Acquisitions
Table 20. Global Plasma-derived Therapies Market Size by Regions 2024-2029 ($ Millions)
Table 21. Global Plasma-derived Therapies Market Size Market Share by Regions 2024-2029
Table 22. United States Plasma-derived Therapies Market Size by Type (2024-2029) ($ Millions)
Table 23. United States Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Table 24. United States Plasma-derived Therapies Market Size by Application (2024-2029) ($ Millions)
Table 25. United States Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Table 26. Europe Plasma-derived Therapies Market Size by Type (2024-2029) ($ Millions)
Table 27. Europe Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Table 28. Europe Plasma-derived Therapies Market Size by Application (2024-2029) ($ Millions)
Table 29. Europe Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Table 30. China Plasma-derived Therapies Market Size by Type (2024-2029) ($ Millions)
Table 31. China Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Table 32. China Plasma-derived Therapies Market Size by Application (2024-2029) ($ Millions)
Table 33. China Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Table 34. Rest of World Plasma-derived Therapies Market Size by Type (2024-2029) ($ Millions)
Table 35. Rest of World Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Table 36. Rest of World Plasma-derived Therapies Market Size by Application (2024-2029) ($ Millions)
Table 37. Rest of World Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Table 38. Key Market Drivers & Growth Opportunities of Plasma-derived Therapies
Table 39. Key Market Challenges & Risks of Plasma-derived Therapies
Table 40. Key Industry Trends of Plasma-derived Therapies
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. CSL Behring LLC Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. CSL Behring LLC Plasma-derived Therapies Market Size (2023 VS 2029)
Table 55. Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Shire Plasma-derived Therapies Market Size (2023 VS 2029)
Table 57. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Bayer Plasma-derived Therapies Market Size (2023 VS 2029)
Table 59. Kedrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Kedrion Plasma-derived Therapies Market Size (2023 VS 2029)
Table 61. Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Takeda Plasma-derived Therapies Market Size (2023 VS 2029)
Table 63. Biotest Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Biotest Plasma-derived Therapies Market Size (2023 VS 2029)
Table 65. Octaparma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Octaparma Plasma-derived Therapies Market Size (2023 VS 2029)
Table 67. Bio Products Laboratory (BPL) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2023 VS 2029)
Table 69. LFB Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. LFB Plasma-derived Therapies Market Size (2023 VS 2029)
Table 71. Grifols Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Grifols Plasma-derived Therapies Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Plasma-derived Therapies
Figure 2. Plasma-derived Therapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Therapies Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Plasma-derived Therapies Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Plasma-derived Therapies Market Size Market Share by Type (2024-2029)
Figure 9. Global Albumin Market Size Growth Rate
Figure 10. Global Immunoglobulin Market Size Growth Rate
Figure 11. Global Factor VIII Market Size Growth Rate
Figure 12. Global Others Market Size Growth Rate
Figure 13. Plasma-derived Therapies in Hemophilia
Figure 14. Global Plasma-derived Therapies Market: Hemophilia (2024-2029) ($ Millions)
Figure 15. Plasma-derived Therapies in Primary Immunodeficiencies (PIDs)
Figure 16. Global Plasma-derived Therapies Market: Primary Immunodeficiencies (PIDs) (2024-2029) ($ Millions)
Figure 17. Plasma-derived Therapies in Idiopathic Thrombocytopenic Purpura (ITP)
Figure 18. Global Plasma-derived Therapies Market: Idiopathic Thrombocytopenic Purpura (ITP) (2024-2029) ($ Millions)
Figure 19. Plasma-derived Therapies in COVID-19
Figure 20. Global Plasma-derived Therapies Market: COVID-19 (2024-2029) ($ Millions)
Figure 21. Plasma-derived Therapies in Others
Figure 22. Global Plasma-derived Therapies Market: Others (2024-2029) ($ Millions)
Figure 23. Global Plasma-derived Therapies Market Size Market Share by Application (2024-2029)
Figure 24. Global Plasma-derived Therapies Market Size in Hemophilia Growth Rate
Figure 25. Global Plasma-derived Therapies Market Size in Primary Immunodeficiencies (PIDs) Growth Rate
Figure 26. Global Plasma-derived Therapies Market Size in Idiopathic Thrombocytopenic Purpura (ITP) Growth Rate
Figure 27. Global Plasma-derived Therapies Market Size in COVID-19 Growth Rate
Figure 28. Global Plasma-derived Therapies Market Size in Others Growth Rate
Figure 29. Funding/Investment
Figure 30. Global Plasma-derived Therapies Market Size Market Share by Regions 2024-2029
Figure 31. United States Plasma-derived Therapies Market Size 2024-2029 ($ Millions)
Figure 32. China Plasma-derived Therapies Market Size 2024-2029 ($ Millions)
Figure 33. Europe Plasma-derived Therapies Market Size 2024-2029 ($ Millions)
Figure 34. Rest of World Plasma-derived Therapies Market Size 2024-2029 ($ Millions)
Figure 35. United States Plasma-derived Therapies Consumption Market Share by Type in 2029
Figure 36. United States Plasma-derived Therapies Market Size Market Share by Application in 2029
Figure 37. China Plasma-derived Therapies Consumption Market Share by Type in 2029
Figure 38. China Plasma-derived Therapies Market Size Market Share by Application in 2029
Figure 39. Europe Plasma-derived Therapies Consumption Market Share by Type in 2029
Figure 40. Europe Plasma-derived Therapies Market Size Market Share by Application in 2029
Figure 41. Rest of World Plasma-derived Therapies Consumption Market Share by Type in 2029
Figure 42. Rest of World Plasma-derived Therapies Market Size Market Share by Application in 2029